110 related articles for article (PubMed ID: 1311784)
21. Rat parietal cell function after prolonged inhibition of gastric acid secretion.
Larsson H; Carlsson E; Ryberg B; Fryklund J; Wallmark B
Am J Physiol; 1988 Jan; 254(1 Pt 1):G33-9. PubMed ID: 2827515
[TBL] [Abstract][Full Text] [Related]
22. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
23. The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
Zhang Q; Huang N; Wang J; Luo H; He H; Ding M; Deng WQ; Zou K
Fitoterapia; 2013 Sep; 89():210-7. PubMed ID: 23742858
[TBL] [Abstract][Full Text] [Related]
24. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of hydrogen-potassium-stimulated adenosine triphosphatase: effects on acid secretion, plasma gastrin, and the gastric mucosa.
McGuigan JE
Gastroenterology; 1989 Oct; 97(4):1045-8. PubMed ID: 2550308
[No Abstract] [Full Text] [Related]
26. [Application of proton pump inhibitor to special conditions; Zollinger-Ellison syndrome].
Tani N
Nihon Rinsho; 1992 Jan; 50(1):154-9. PubMed ID: 1347327
[TBL] [Abstract][Full Text] [Related]
27. [Protective effect of proton pump inhibitor on the gastric mucosa].
Kawano S; Tsuji S; Masuda E; Hayashi N; Tsujii M; Michida T; Kobayashi I; Fusamoto H; Kamada T
Nihon Rinsho; 1992 Jan; 50(1):33-8. PubMed ID: 1311787
[TBL] [Abstract][Full Text] [Related]
28. [Recurrent peptic ulcer after gastric surgery].
Sugiyama M; Katamura H
Nihon Rinsho; 1992 Jan; 50(1):144-53. PubMed ID: 1311781
[TBL] [Abstract][Full Text] [Related]
29. Biological basis of omeprazole therapy.
Sachs G; Wallmark B
J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic effect of gastrozolum in stomach ulcers].
Sukhareva GV; Tsaregorodtseva TM; Trubitsina IE; Serova TI; Goncharenko LS; Dolgova NIu; Zarudnaia SI; Kuz'mina OS; Lopatina IN; Manannikov IV; Melik-Ogandzhanian NB
Eksp Klin Gastroenterol; 2003; (5):25-30, 192. PubMed ID: 14621606
[TBL] [Abstract][Full Text] [Related]
31. [Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)].
Andriulli A; Mangia A; Lawson F
Minerva Gastroenterol Dietol; 1991; 37(3):135-40. PubMed ID: 1686409
[TBL] [Abstract][Full Text] [Related]
32. [Relapse of peptic ulcer after quick healing induced by proton pump inhibitors].
Tsukamoto Y; Niwa Y; Arisawa T
Nihon Rinsho; 1992 Jan; 50(1):174-80. PubMed ID: 1371814
[TBL] [Abstract][Full Text] [Related]
33. [Clinico-pharmacological evaluation of omeprazole, as a proton pump inhibitor, compared with H2-blockers].
Nakashima M; Kanamaru M
Nihon Rinsho; 1992 Jan; 50(1):60-7. PubMed ID: 1347331
[TBL] [Abstract][Full Text] [Related]
34. [Effect of proton pump inhibitor, in combination with epidermal growth factor, on the healing of chronic gastric ulcer in submandibular gland removed rats].
Imai S; Itoh M; Yokoyama Y; Joh T; Takeuchi T
Nihon Rinsho; 1992 Jan; 50(1):39-44. PubMed ID: 1311788
[TBL] [Abstract][Full Text] [Related]
35. Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach.
Lee H; Håkanson R; Karlsson A; Mattsson H; Sundler F
Digestion; 1992; 51(3):125-32. PubMed ID: 1355746
[TBL] [Abstract][Full Text] [Related]
36. Omeprazole: its influence on gastric acid secretion, gastrin and ECL cells.
Larsson H; Håkanson R; Mattsson H; Ryberg B; Sundler F; Carlsson E
Toxicol Pathol; 1988; 16(2):267-72. PubMed ID: 3187355
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of gastric acid secretion: advantages and risks in short and long-term treatment.
Mazzacca G; Sabbatini F
Ital J Gastroenterol; 1990; 22 Suppl 1():11-2. PubMed ID: 1983419
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
Yukawa K; Yukawa E
Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
[TBL] [Abstract][Full Text] [Related]
39. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
40. New perspectives in gastric acid suppression: genetic polymorphisms predict the efficacy of proton pump inhibitors.
Egan LJ; Murray JA
Dig Dis; 2000; 18(2):58-63. PubMed ID: 11060468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
